The aim of the present study was to pharmacologically assess the contribution of the central RAS to the hypertension in BPH/2J mice using acute and chronic intracerebroventricular (ICV) administration of AT1 receptor antagonists. The gene discussed is AGTR1; the disease is hypertensive disorder.